Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months

Background: Although buprenorphine/naloxone (bup/nal) is well-established as a safe and effective treatment for opioid use disorders (OUDs), there are few studies reporting 12-month outcomes of patients receiving bup/nal in formerly drug-free outpatient programs. Objectives: To examine 12-month outc...

Full description

Bibliographic Details
Main Authors: Gryczynski, J. (Author), Jaffe, J.H (Author), Mitchell, S.G (Author), Monico, L.B (Author), O’Grady, K.E (Author), Schwartz, R.P (Author)
Format: Article
Language:English
Published: Taylor and Francis Ltd 2018
Subjects:
Online Access:View Fulltext in Publisher